Circulating CD36 Is Reduced in HNF1A-MODY Carriers

Introduction Premature atherosclerosis is a significant cause of morbidity and mortality in type 2 diabetes mellitus. Maturity onset diabetes of the young (MODY) accounts for approximately 2% of all diabetes, with mutations in the transcription factor; hepatocyte nuclear factor 1 alpha (HNF1A) accounting for the majority of MODY cases. There is somewhat limited data available on the prevalence of macrovascular disease in HNF1A-MODY carriers with diabetes. Marked insulin resistance and the associated dyslipidaemia are not clinical features of HNF1A-MODY carriers. The scavenger protein CD36 has been shown to play a substantial role in the pathogenesis of atherosclerosis, largely through its interaction with oxidised LDL. Higher levels of monocyte CD36 and plasma CD36(sCD36) are seen to cluster with insulin resistance and diabetes. The aim of this study was to determine levels of sCD36 in participants with HNF1A-MODY diabetes and to compare them with unaffected normoglycaemic family members and participants with type 2 diabetes mellitus. Methods We recruited 37 participants with HNF1A-MODY diabetes and compared levels of sCD36 with BMI-matched participants with type 2 diabetes mellitus and normoglycaemic HNF1A-MODY negative family controls. Levels of sCD36 were correlated with phenotypic and biochemical parameters. Results HNF1A-MODY participants were lean, normotensive, with higher HDL and lower triglyceride levels when compared to controls and participants with type 2 diabetes mellitus. sCD36 was also significantly lower in HNF1A-MODY participants when compared to both the normoglycaemic family controls and to lean participants with type 2 diabetes mellitus. Conclusion In conclusion, sCD36 is significantly lower in lean participants with HNF1A-MODY diabetes when compared to weight-matched normoglycaemic familial HNF1A-MODY negative controls and to lean participants with type 2 diabetes mellitus. Lower levels of this pro-atherogenic marker may result from the higher HDL component in the lipid profile of HNF1A-MODY participants.

• Publication year

  2013

• Venue

  PLoS ONE

• Publication date

  2013-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pone.0074577PMID 24069322PMCID 3771933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test. Diabetes Care 2001;24:539–548

  2014cited by this paper
• „Maturity onset diabetes of the young“

  2012cited by this paper
• Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

  2012cited by this paper
• High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes

  2011cited by this paper
• Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women

  2011cited by this paper
• Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells[S]

  2011cited by this paper
• Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene

  2010cited by this paper
• Enhanced Hepatic apoA-I Secretion and Peripheral Efflux of Cholesterol and Phospholipid in CD36 Null Mice

  2010cited by this paper
• Assessment of High-Sensitivity C-Reactive Protein Levels as Diagnostic Discriminator of Maturity-Onset Diabetes of the Young Due to HNF1A Mutations

  2010cited by this paper
• Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients.

  2010cited by this paper
• Maturity-onset diabetes of the young (MODY): how many cases are we missing?

  2010cited by this paper
• Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk.

  2010cited by this paper
• Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis

  2009cited by this paper
• Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability

  2008cited by this paper
• Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma: A Novel Marker of Insulin Resistance

  2006cited by this paper
• Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers.

  2005cited by this paper
• β-Cell Dysfunction, Insulin Sensitivity, and Glycosuria Precede Diabetes in Hepatocyte Nuclear Factor-1α Mutation Carriers

  2005cited by this paper
• Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations

  2004cited by this paper
• Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.

  2004cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages*

  2002cited by this paper
• A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions*

  2002cited by this paper
• Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics

  2002cited by this paper
• Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice.

  2000cited by this paper
• Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state

  2000cited by this paper
• A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism*

  1999cited by this paper
• Liver‐enriched transcription factors and hepatocyte differentiation

  1996cited by this paper

• Systematic Review of Monogenic Diabetes Prognostics

  2023cites this paper
• Novel insights into genetics and clinics of the HNF1A-MODY

  2019cites this paper
• Lipid-associated genetic polymorphisms are associated with FBP and LDL-c levels among myocardial infarction patients in Chinese population.

  2018cites this paper
• Quantitative Evaluation of Serum Proteins Uncovers a Protein Signature Related to Maturity-Onset Diabetes of the Young (MODY).

  2018cites this paper
• Intima-media thickness and endothelial dysfunction in GCK and HNF 1 A-MODY patients

  2015cites this paper
• Undiagnosed MODY: Time for Action

  2015cites this paper
• Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.

  2015cites this paper